Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study

NCT03314012 is registered in ClinicalTrials.gov with Cibiem, Inc. as lead sponsor.

NCT NCT03314012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03314012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
Lead sponsor
Cibiem, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
December 11, 2015
Completion date
January 31, 2020
Enrollment
39 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension,essential